Browsing Over 32 Presentations

Sort By
Welcome to ESMO Gynae 2021 and Keynote address Opening and closure session

Keynote lecture: DNA damage repair in ovarian cancer and PARP inhibitors resistance (ID 23)

Lecture Time
12:55 - 13:20
Speakers
  • A. M. Oza (Toronto, Canada, Ontario)
Session Name
Welcome to ESMO Gynae 2021 and Keynote address
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
12:45 - 13:20
Immunotherapy in ovarian cancer: Is there a future in clinical practice? Controversy session

Yes (ID 18)

Lecture Time
16:15 - 16:30
Speakers
  • E. Pujade-Lauraine (Paris, France, CEDEX 4)
Session Name
Immunotherapy in ovarian cancer: Is there a future in clinical practice?
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
16:00 - 17:00
Treatment and biomarkers of recurrent ovarian cancer: Where are we in 2021 and what’s next? Educational session

Surgery in recurrent ovarian cancer: Patient selection and impact on 2nd line therapeutic strategies (ID 13)

Lecture Time
14:30 - 14:50
Speakers
  • P. Harter (Essen, Germany, 45219)
Session Name
Treatment and biomarkers of recurrent ovarian cancer: Where are we in 2021 and what’s next?
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
14:30 - 15:45
1st line maintenance strategy options for advanced ovarian cancer by HRD profile Clinical case session

Clinical case - What options for HRD patients? Criteria for treatment choice (ID 8)

Lecture Time
15:05 - 15:25
Speakers
  • E. C. Kohn (Bethesda, United States of America)
Session Name
1st line maintenance strategy options for advanced ovarian cancer by HRD profile
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
15:05 - 16:20
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? Educational session

The evolving role of molecular profiling for therapeutic stratification in newly diagnosed ovarian cancer (ID 3)

Lecture Time
13:35 - 13:50
Speakers
  • D. Tan (Singapore, Singapore)
Session Name
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next?
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
13:35 - 14:50
How to deal with the different challenges in your professional career YO Session

How to start an international collaboration - Developing and integrating research in clinical practice (ID 30)

Lecture Time
18:00 - 18:10
Speakers
  • M. Mirza (Copenhagen, Denmark)
Session Name
How to deal with the different challenges in your professional career
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
17:50 - 19:05
Authors
  • M. Mirza (Copenhagen, Denmark)
Best of abstracts session Abstract session

Live Q&A and discussion (ID 25)

Lecture Time
13:15 - 13:30
Session Name
Best of abstracts session
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15
Immunotherapy in ovarian cancer: Is there a future in clinical practice? Controversy session

Live Q&A and discussion (ID 20)

Lecture Time
16:45 - 17:00
Session Name
Immunotherapy in ovarian cancer: Is there a future in clinical practice?
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
16:00 - 17:00
Treatment and biomarkers of recurrent ovarian cancer: Where are we in 2021 and what’s next? Educational session

Current and emerging biomarkers in recurrent OvCa (ID 15)

Lecture Time
15:10 - 15:30
Speakers
  • S. Banerjee (London, United Kingdom)
Session Name
Treatment and biomarkers of recurrent ovarian cancer: Where are we in 2021 and what’s next?
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
14:30 - 15:45
1st line maintenance strategy options for advanced ovarian cancer by HRD profile Clinical case session

Clinical case - Combination vs sequence: Clinical implications (ID 10)

Lecture Time
15:45 - 16:05
Speakers
  • S. Lheureux (Toronto, Canada, Ontario)
Session Name
1st line maintenance strategy options for advanced ovarian cancer by HRD profile
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
15:05 - 16:20
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? Educational session

First line maintenance therapy for ovarian cancer in 2021: What are the options? (ID 5)

Lecture Time
14:05 - 14:20
Speakers
  • I. L. Ray-Coquard (Lyon, France, CEDEX)
Session Name
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next?
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
13:35 - 14:50
How to deal with the different challenges in your professional career YO Session

Live Q&A and discussion (ID 32)

Lecture Time
18:20 - 19:05
Session Name
How to deal with the different challenges in your professional career
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
17:50 - 19:05